Drug Trial Radar · NCT07436221
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma
Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Feb 28, 2026
Primary completion
Dec 27, 2026
Study completion Feb 26, 2027
Sponsor
- Lead sponsor
- AkesoIndustry
- Sponsor type
- Industry
- First posted
- Feb 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.
Conditions
- Asthma
Interventions
AK139Drug
AK139 regimen 1- subcutaneous injection.
AK139Drug
AK139 regimen 2- subcutaneous injection.
AK139Drug
AK139 regimen 3- subcutaneous injection.
PlaceboDrug
subcutaneous injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute change from baseline in pre-bronchodilator FEV1Time frame: Up to week 12
- Absolute change and percent change from baseline in FENOTime frame: Up to week 12
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Shanghai General Hospital
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.